These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28120478)

  • 41. Content variability of active drug substance in compounded oral 3,4-diaminopyridine products.
    Green DM; Jones AC; Brain KR
    J Clin Pharm Ther; 2012 Feb; 37(1):53-7. PubMed ID: 21501202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stability of allopurinol and of five antineoplastics in suspension.
    Dressman JB; Poust RI
    Am J Hosp Pharm; 1983 Apr; 40(4):616-8. PubMed ID: 6846371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are you asking the right questions.
    Kuehn BM
    J Am Vet Med Assoc; 2004 Sep; 225(6):801-2. PubMed ID: 15485028
    [No Abstract]   [Full Text] [Related]  

  • 44. Problems associated with veterinary compounding in swine practice.
    McKean JD
    J Am Vet Med Assoc; 1994 Jul; 205(2):279-83. PubMed ID: 7928598
    [No Abstract]   [Full Text] [Related]  

  • 45. Evaluation of sources to document extended shelf lives of compounded cytostatics.
    Larsson I; Kart T
    J Oncol Pharm Pract; 2013 Dec; 19(4):355-64. PubMed ID: 23235919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Leukemia following chemotherapy for ovarian cancer.
    Kaldor JM; Day NE; Pettersson F; Clarke EA; Pedersen D; Mehnert W; Bell J; Høst H; Prior P; Karjalainen S
    N Engl J Med; 1990 Jan; 322(1):1-6. PubMed ID: 2104664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study.
    Curry SL; Blessing JA; DiSaia PJ; Soper JT; Twiggs LB
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):357-62. PubMed ID: 2536911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quality assessment of fluconazole capsules and oral suspensions compounded by pharmacies located in the United States.
    Laporte CM; Cruz-Espindola C; Thungrat K; Schick AE; Lewis TP; Boothe DM
    Am J Vet Res; 2017 Apr; 78(4):421-432. PubMed ID: 28346002
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs.
    Lam MS
    Pharmacotherapy; 2011 Feb; 31(2):164-92. PubMed ID: 21275495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Doxycycline concentration over time after storage in a compounded veterinary preparation.
    Papich MG; Davidson GS; Fortier LA
    J Am Vet Med Assoc; 2013 Jun; 242(12):1674-8. PubMed ID: 23725430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stability of three commonly compounded extemporaneous enrofloxacin suspensions for oral administration to exotic animals.
    Petritz OA; Guzman DS; Wiebe VJ; Papich MG
    J Am Vet Med Assoc; 2013 Jul; 243(1):85-90. PubMed ID: 23786194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of myeloma. Comparison of melphalan, chlorambucil, and azathioprine.
    Arch Intern Med; 1975 Jan; 135(1):157-62. PubMed ID: 1111464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents.
    Bosanquet AG
    Cancer Chemother Pharmacol; 1985; 14(2):83-95. PubMed ID: 3882257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency.
    Branten AJ; Reichert LJ; Koene RA; Wetzels JF
    QJM; 1998 May; 91(5):359-66. PubMed ID: 9709470
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Compounding of Veterinary Drugs for Equine Practitioners.
    Stanley SD; Moffitt K; Wiebe V
    Vet Clin North Am Equine Pract; 2017 Apr; 33(1):213-225. PubMed ID: 28325180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy.
    Pinkerton JV; Pickar JH
    Menopause; 2016 Feb; 23(2):215-23. PubMed ID: 26418479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AVMA guidelines on compounding.
    Upson D
    J Am Vet Med Assoc; 1994 Jul; 205(2):199-200. PubMed ID: 7928573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of the M-2 protocol in previously untreated patients with advanced multiple myeloma.
    Gössinger H; Bettelheim P; Neumann E; Hinterberger W; Korninger K; Niessner H; Pabinger-Fasching I; Bauer K; Lechner K
    Blut; 1984 Nov; 49(5):383-8. PubMed ID: 6548652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dynamics of preparation of parenteral and other drugs by veterinary practitioners.
    Stowe CM
    J Am Vet Med Assoc; 1988 Jan; 192(2):262-4. PubMed ID: 3280538
    [No Abstract]   [Full Text] [Related]  

  • 60. Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report.
    Pope G; Daleo C; Batson SL
    Int J Pharm Compd; 2019; 23(5):358-364. PubMed ID: 31513533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.